Endoskopie 2008; 17(3): 71-73

Laparoscopic hysterectomy in a teaching hospital

MUDr. Eduard Kučera CSc
Ústav pro péči o matku a dítě, Praha-Podolí

The laparoscopic assisted vaginal hysterectomy (LAVH) was introduced in the year 1988. Since this date we register a wide spread

of this technique in gynecologic surgery for benign and malignant disease. It combines two very advantageous operative access – vaginal

and laparoscopic. Until now there were published also other different types of laparosopic hysterectomy e. g. total laparoscopic

hysterectomy (TLH). This article is a review of different types of laparoscopic hysterectomy and their indications. It also presents author

´s personal exeperience with this technique and the position of laparoscopic hysterectomy in the teaching hospital.

Keywords: hysterectomy, laparoscopic hysterectomy, LAVH, TLH, teaching hospital, operation indication, complication.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kučera E. Laparoscopic hysterectomy in a teaching hospital. Endoskopie. 2008;17(3):71-73.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Donnez O, Jadoul P, Squifflet J, Donnez J. A series of 3190 laparoscopic hysterectomies for benign disease from 1990 to 2006: evaluation of complications compared with vaginal and abdominal procedures. Br. J.Obstet. Gynecol. 2008; Nov. 11. Go to original source... Go to PubMed...
    2. Drahoňovský J, Pán M, Barešová Š, Kučera E, Feyereisl J. Klinické srovnání laparoskopicky asistované vaginální hysterektomie (LAVH) a totální laparoskopické hysterektomie (TLH) u žen s benigním onemocněním dělohy - prospektivní randomizovaná studie. Čes. Gynek. 2006; 71: 431-437.
    3. Gor HB. Hysterectomy. www.emedicine.com, 2008.
    4. Holub Z, Kužel D, Kučera E, et al. Management děložních myomů: CSGE doporučení k provádění správné klinické praxe. Čes. Gynek. 2005; 70: 165-168.
    5. Jacobson GF, Shaber RE, Armstrong MA, Hung YY. Hysterectomy rates for benign indications. Obstet. Gynecol. 2006; 107: 1278-1283. Go to original source... Go to PubMed...
    6. Johnson N, Barlow D, Lethaby A, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. Apr 2006; 19: CD003677. Go to original source... Go to PubMed...
    7. Kachlik D, Baca V, Bozdechova I, et al. Anatomical terminology and nomenclature: past, present and highlights. Surg. Radiol. Anat. 2008; 30: 459-466. Go to original source... Go to PubMed...
    8. Kučera E, Holub Z, Svobodova G. Laparoscopic oophorectomy either with or without hysterectomy for early breast cancer. Eur. J.Gynael. Oncol. 2007; 28: 294-296. Go to original source...
    9. Kučera E. Laparoskopický přístup k operačnímu řešení karcinomu endometria. Postgraduální medicína 2008; 10(1): 401-406.
    10. Novotný Z, Králíčková M, Smitková V. Hodnocení vývoje laparoskopicky asistované vaginální hysterektomie v ČR za posledních 10 let na základě dat z Národního registru komplikací gynekologické laparoskopie. Čes. Gynek. 2007; 72: 109-112.
    11. Reich H. Laparoscopic hysterectomy. Surg. Laparosc. Endosc. 1992; 2: 85-88. Go to PubMed...
    12. Sehnal B, Sottner O, Zahumensky J, et al. Comparison of three hysterectomy methods in a set of female to male transsexuals. Geburtshilfe und Frauenheilkunde 2008; 68: 625-628. Go to original source...
    13. Tošner J. Faktory ovlivňující provedení hysterektomie. Gynekolog 2003; 12: 8-15.
    14. Urdzík P, Dankovčík R, Ostró A, et al. Tamoxifen, karcinóm endometria a levonorgestrel intrauterinný systém - Mirena. Acta chemotherapeutica: časopis Slovenskej chemoterapeutickej spoločnosti SLS 2006; 16: 24-27.

    Return to the content


    Endoscopy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.